OncoDaily Party 2026: Madrid Midnight
20 Posts Not To Miss From ASCOQLTY26
Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease
Humaid Al-Shamsi: KHCC’s Role in Advancing Cancer Research Across the Arab World
Amanda Pullinger: Bringing East and West Together to Improve the Gastric Cancer Patient Journey
Caregiver Burnout – An Unrecognised Challenge in Oncology
Anjali Sibley and Angelina Lorello at COGC 2026: Remember Your Why, Keep the Patient at the Center
10 Must-Read Posts In GI Oncology This Week
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
